Regarding AML and MDS harboring TP53 mutations, the newest data showed an evasive immune phenotype characterized by the overexpression of PD-L1, associated with miR-34a expression [127], reduced numbers of both cytotoxic and helper T cells and the expansion of T-regs and MDSCs [38]. Here, TP53 is linked to acute myeloid leukemia.